Back to Home

Deffai Documentation

FDA Filing Analysis

Submit and analyze FDA regulatory documents with AI-powered evaluation

Overview

The FDA Filing Analysis module uses three specialized AI agents to evaluate 510(k), PMA, and De Novo submissions. Each agent focuses on a specific aspect: clinical safety, operational efficiency, and regulatory compliance. The consensus algorithm combines their insights to provide a balanced assessment and approval likelihood score.

Supported Documents: 510(k) Premarket Notifications, PMA Applications, De Novo Requests, and related FDA submission documents in PDF or Word format.

How It Works

1

Upload Your Document

Select your FDA submission document or choose from our demo files to see the system in action.

Accepted formats: .pdf, .doc, .docx
Maximum file size: 50MB
2

Preview Document

Use the preview feature to verify you're submitting the correct document. For demo documents, you can see the full content including clinical data and regulatory sections.

3

AI Analysis

Three AI agents analyze your document simultaneously:

Clinical Agent: Evaluates patient safety data
Operations Agent: Assesses manufacturing and testing
Regulatory Agent: Checks compliance requirements
4

Review Results

Receive a comprehensive consensus report including approval likelihood percentage, key findings from each agent, and specific recommendations for improvement.

Understanding Your Results

Approval Likelihood Score

80-100%: High likelihood of approval
60-79%: Moderate likelihood, address recommendations
Below 60%: Significant improvements needed

Agent Scores

Each agent provides an individual score based on their domain expertise:

  • Clinical Score: Based on safety data, adverse events, and patient outcomes
  • Operations Score: Based on manufacturing controls, testing, and quality systems
  • Regulatory Score: Based on compliance with FDA requirements and documentation completeness

Best Practices

Complete Documentation

Ensure your submission includes all required sections: device description, intended use, substantial equivalence (for 510(k)), clinical data, and testing results.

Quality Clinical Data

Include comprehensive clinical trial data with clear endpoints, statistical analysis, and adverse event reporting for the best assessment results.

Review Agent Feedback

Pay attention to specific recommendations from each agent. Address critical issues before submitting to the FDA to improve approval chances.

Iterative Improvement

Use Deffai throughout your submission preparation process. Run multiple analyses as you update your documentation to track improvement.

Common Issues & Solutions

Low Clinical Score

Usually indicates insufficient clinical data or unclear safety profile. Add more patient outcome data and adverse event analysis.

Regulatory Compliance Issues

Check that all FDA-required sections are present and properly formatted. Use the FDA's official guidance documents as reference.

File Upload Errors

Ensure your file is under 50MB and in PDF or Word format. Try converting to PDF if you experience issues with Word documents.

Try a Demo Document

Experience the full analysis workflow with our pre-loaded FDA submission examples.

Go to FDA Filing Analysis